KW
BBH icon

KWB Wealth’s VanEck Biotech ETF BBH Stock Holding History

KWB Wealth’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,352
Closed -$216K – 126
2023
Q1 		$216K Hold
1,352
– – 0.04% 114
2022
Q4 		$216K Buy
+1,352
New +$214K 0.04% 108

Other funds holding BBH

MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
TIA
Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

KWB Wealth's BBH Position: Q2 2023 in Review

KWB Wealth sold out of VanEck Biotech ETF (BBH) in Q2 2023, closing a stake of 1,352 shares — an estimated $216K sold.

KWB Wealth first reported a position in BBH in Q4 2022 and held it in 2 quarters. The position peaked at $216K in Q1 2023. 111 funds tracked by Wall St. Rank hold BBH as of Q2 2023.

  • KWB Wealth reported no remaining VanEck Biotech ETF position as of Q2 2023 after selling out during the quarter.
  • KWB Wealth sold 1,352 VanEck Biotech ETF shares in Q2 2023, an estimated $216K.
  • KWB Wealth first reported a position in VanEck Biotech ETF in Q4 2022 and held it in 2 quarters.
  • KWB Wealth's VanEck Biotech ETF position peaked at $216K in Q1 2023.
  • 111 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2023.

Based on KWB Wealth's 13F filing for Q2 2023, filed 24 Jul 2023.